Results 41 to 50 of about 28,857 (204)
The clinical efficacy of fluconazole in the treatment of vulvovaginal candidiasis
The article tells about the key problems of diagnosis and treatment of patients with vulvovaginal candidiasis (VVC). Candida albicans causes 75--80% of candidiasis cases.
V. N. Serov +3 more
doaj +1 more source
Antimicrobial photodynamic therapy in Candida spp. biofilms: In vitro and in vivo protocols
This review addresses the critical challenges in translating in vitro antimicrobial photodynamic therapy protocols to in vivo models, with a particular focus on the hurdles of standardization. The vast diversity in photosensitizers and light parameters across different target cells and models requires a rigorous optimization process.
Lívia Mara Alves Figueiredo‐Godoi +2 more
wiley +1 more source
is the most common etiological agent for vulvovaginal candidiasis (VVC); however, other species may also occasionally be responsible for this disease. The classical signs and symptoms include intense pruritus, curdy vaginal discharge, dyspareunia, sometimes dysuria, genital discomfort, pain, diminished sexual pleasure, and psychological suffering.
+6 more sources
Efficacy of metronidazole and miconazole vaginal co-formulation for bacterial vaginosis and vulvovaginal candidiasis [PDF]
E.A. Markova Pirogov Russian National Research Medical University, Moscow, Russian Federation Recurrent vulvovaginal infections being an epidemiological and clinical issue also have social and psychological implications.
E.A. Markova
doaj
Exploring the Genetic Diversity of Candida albicans in Animal Hosts: A One Health Perspective
ABSTRACT Introduction Candida albicans is an important priority fungal pathogen that commonly colonizes humans and a wide range of animal hosts, although its population structure in wildlife remains poorly explored. Methods In this study, 41 C. albicans isolates obtained from Italian wild animals (European hedgehogs, wolves, foxes, badgers, roe deer ...
Lucilla Lo Re +9 more
wiley +1 more source
Differentiated approach to the treatment of various forms of vulvovaginal candidiasis [PDF]
The article presents data on the results of examination and treatment of 55 patients with a diagnosis of «vulvovaginal candidiasis». In the study, the analysis of anamnestic data, and in addition, the clinical evaluation of vaginal discharge and the ...
T Yu Pestrikova +4 more
doaj
Sertaconazole in the treatment of vulvovaginal candidiasis
Vulvovaginal candidiasis today is one of the most pressing problems in the field of women’s health. However, the prevalence of Candida with formed drug resistance to fluconazole significantly complicates the treatment of this disease.
Z. N. Efendieva
doaj +1 more source
Ribes nigrum extract‐loaded PLGA/chitosan nanoparticles is developed as a vaginal drug delivery system for vulvovaginal candidiasis. The chitosan‐coated nanoparticles exhibit favorable physicochemical properties, strong mucoadhesion, sustained release for up to 2 weeks, excellent biocompatibility, and potent antifungal activity against Candida ...
Ayca Aslan Aras +6 more
wiley +1 more source
Vulvovaginal candidiasis-related symptoms and conditions.
Vulvovaginal candidiasis-related symptoms and conditions.
Brendan R. Jackson (8575074) +2 more
core +1 more source
Comparison of Depression, Anxiety, Stress, and Health-Related Quality of Life in Patients with Recurrent and Acute Vulvovaginal Candidiasis [PDF]
Introduction: Vulvovaginal candidiasis is one of the most common fungal infections in women, affecting approximately 80% of them. The recurrent form, due to prolonged antifungal use and drug resistance, reduces quality of life and increases treatment ...
Fahimeh Baghbani +8 more
doaj +1 more source

